Exagen Inc.
XGN
$4.36
$0.051.16%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 11.67% | 21.79% | 37.87% | 14.19% | 7.51% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.67% | 21.79% | 37.87% | 14.19% | 7.51% |
| Cost of Revenue | 11.39% | 43.40% | 29.73% | 13.30% | 9.59% |
| Gross Profit | 11.86% | 8.60% | 44.32% | 14.79% | 6.11% |
| SG&A Expenses | 7.69% | 21.76% | 12.61% | 10.30% | 6.28% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.84% | 26.81% | 18.49% | 12.36% | 8.30% |
| Operating Income | -1.46% | -47.06% | 33.52% | -1.66% | -12.05% |
| Income Before Tax | -4.77% | -24.30% | -40.93% | -48.42% | -11.67% |
| Income Tax Expenses | -- | 8.33% | -- | -- | -- |
| Earnings from Continuing Operations | -5.73% | -24.25% | -40.95% | -49.66% | -11.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.73% | -24.25% | -40.95% | -49.66% | -11.67% |
| EBIT | -1.46% | -47.06% | 33.52% | -1.66% | -12.05% |
| EBITDA | 3.76% | -47.41% | 41.33% | -0.28% | -14.93% |
| EPS Basic | 17.75% | 2.89% | -12.16% | -28.98% | -8.01% |
| Normalized Basic EPS | 0.24% | -30.50% | 30.10% | -6.67% | -8.03% |
| EPS Diluted | 17.75% | 2.89% | -12.16% | -28.98% | -8.01% |
| Normalized Diluted EPS | 0.24% | -30.50% | 30.10% | -6.67% | -8.03% |
| Average Basic Shares Outstanding | 28.55% | 27.93% | 25.67% | 15.99% | 3.42% |
| Average Diluted Shares Outstanding | 28.55% | 27.93% | 25.67% | 15.99% | 3.42% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |